Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus in PIK3CA-mutated/amplified refractory solid tumors
NCT02449564Phase 2Completed
- Sponsor
- Samsung Medical Center
- Start
- Nov 2014
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in solid tumor, sponsored by Samsung Medical Center. Started Nov 2014; status: completed.
02
Drugs
sirolimus
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT02449564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02449564.